Notice Number: NOT-CA-16-043

Key Dates
Release Date: May 3, 2016

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in PA-16-187, "Mechanisms, Models, Measurement, & Management in Pain Research (R21)."

The following section of PA-16-187 has been updated to reflect the participation of NCI in this FOA.

Part 1. Overview Information

The subsections shown below are changed (in italics) to read as follows:

Components of Participating Organizations

National Cancer Institute (NCI)
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Minority Health and Health Disparities (NIMHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.361; 93.866; 93.846; 93.847; 93.279; 93.121; 93.853; 93.213; 93.307, 93.393

Part 2. Section VII. Agency Contacts

With the participation of NCI, the following contacts are added to the FOA.

Scientific/Research Contact(s)
Ann O'Mara, Ph.D., R.N.
National Cancer Institute (NCI)
Telephone: 240-276-7050
Email: [email protected]

Financial/Grants Management Contact(s)
Sean Hine
National Cancer Institute (NCI)
Telephone: 240-276-6291
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Ann O'Mara, Ph.D., R.N.
National Cancer Institute (NCI)
Telephone: 240-276-7050
Email: [email protected]